Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export andsupplier ofMitoxantrone Injection from Surat, Gujarat, India. Mitoxantrone Injection used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.
Tags: Mitoxantrone Injection manufacturer, Mitoxantrone Injection exporter, Mitoxantrone Injection supplier,and Mitoxantrone Injection, whogmp approved Mitoxantrone Injection manufacturer andsupplier, Mitoxantrone Injection distributor, Mitoxantrone Injection shipper,Mitoxantrone Injection 15 ml Mitoxantrone Injection 15 mlsupplier,Mitoxantrone Injection 15 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy Lifescience Mitoxantrone Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Strict Hospital Use & Safe HandlingMitoxantrone Injection is a potent cytotoxic medication and should be handled only by healthcare professionals within a hospital environment. Due to its cytotoxic nature, careful preparation and administration procedures must be followed, ensuring the safety of the patient and medical staff. No preservatives have been added, further highlighting the importance of adhering to hospital protocols.
Therapeutic Applications & EfficacyThis intravenous injection is primarily used for various serious health conditions including multiple types of cancers-breast cancer, acute non-lymphocytic leukemia, non-Hodgkin's lymphoma, and prostate cancer-as well as multiple sclerosis. Its mechanism involves inhibiting DNA replication in malignant cells, thus aiding in reducing disease progression and managing symptoms effectively.
Storage, Stability, and Supply ChainMitoxantrone Injection must be kept in a cool, dry place to maintain its efficacy for its full 2-year shelf life. The product is available in India to authorized dealers, wholesalers, and healthcare suppliers. Quality and authenticity are ensured through regulated distribution, making it accessible for hospital needs while preserving safety standards.
FAQ's of Mitoxantrone Injection:
Q: How should Mitoxantrone Injection be administered?
A: Mitoxantrone Injection is intended for intravenous use only and must be administered by trained healthcare professionals within a hospital setting. The dose and frequency are determined based on the specific condition being treated and must follow prescribed medical protocols.
Q: What are the primary indications for using Mitoxantrone Injection?
A: This injection is used to treat various conditions, including breast cancer, acute non-lymphocytic leukemia, non-Hodgkin's lymphoma, prostate cancer, and multiple sclerosis. The therapy inhibits the growth of abnormal cells and helps manage disease progression.
Q: When is Mitoxantrone Injection typically prescribed during cancer treatment?
A: Mitoxantrone is usually prescribed as part of a combination regimen in specific treatment cycles for cancers or multiple sclerosis. The timing and cycles depend on the patient's individual treatment plan, disease stage, and physician's assessment.
Q: Where should Mitoxantrone Injection be stored for optimal stability?
A: This product should be stored in a cool and dry environment, away from direct sunlight and heat, to maintain its potency and stability throughout its 2-year shelf life.
Q: What is the benefit of using a preservative-free formulation in this injection?
A: A preservative-free preparation reduces the risk of potential adverse reactions and ensures suitability for sensitive patients. It also necessitates strict hospital handling to safeguard product integrity and patient safety.
Q: What precautions should be taken while handling Mitoxantrone Injection?
A: As a cytotoxic agent, it requires specialized handling procedures-medical personnel must use appropriate protective equipment and caution during preparation, administration, and disposal to prevent exposure and contamination.